DAVID A SHERRIS, MD
Medical Practice at Delaware Ave, Buffalo, NY

License number

New York 178951-1

Personal information

See more information about DAVID A SHERRIS at radaris.com

Name

Address

Phone

David Sherris, age 63

51 Nottingham Ter, Buffalo, NY 14216

David A Sherris

1237 Delaware Ave, Buffalo, NY 14209

(716) 884-5102

David A Sherris, age 63

51 Nottingham Ter, Buffalo, NY 14216

(716) 876-7234

David A Sherris

3 Gates Cir, Buffalo, NY 14209

(716) 887-5101

David A Sherris

3 Gates St, Buffalo, NY 14209

(716) 887-5101

Organization information

See more information about DAVID A SHERRIS at bizstanding.com

David Sherris MD

1237 Delaware Ave, Buffalo, NY 14209

Industry:

Ent, Cosmetic Surgery, Plastic Surgery

Site:

clinicoffps.com

Phone:

(716) 884-5102 (Phone)

Description:

There are 4 doctors at this site. Surgery is not performed at this site.

David Allan Sherris

Professional information

See more information about DAVID A SHERRIS at trustoria.com

Professor And Chairman, Department Of Otolaryngology At University At Buffalo

Position:

Fellow and Board Member at American Academy of Facial Plastic & Reconstructive Surgery, President at University at Buffalo Otolaryngology, Inc, Professor and Chairman, Department of Otolaryngology at University at Buffalo, Fellow at American Rhinologic Society

Location:

Buffalo/Niagara, New York Area

Industry:

Medical Practice

Work:

American Academy of Facial Plastic & Reconstructive Surgery since Jan 2010 - Fellow and Board Member University at Buffalo Otolaryngology, Inc - Buffalo, NY since Aug 2003 - President University at Buffalo - Buffalo/Niagara, New York Area since Aug 2003 - Professor and Chairman, Department of Otolaryngology American Rhinologic Society since 1995 - Fellow University at Buffalo 2004 - 2011 - Professor and Chair Otolaryngology Mayo Clinic - Rochester, Minnesota Area Aug 1994 - Jul 2003 - Chief, Division of Facial Plastic Surgery, Department of Otorhinolaryngology

Education:

University of Washington School of Medicine 1993 - 1994
Fellow, Facial Plastic Surgery University of Rochester School of Medicine and Dentistry 1984 - 1993
MD, Medicine and Otolaryngology_Head & Neck Surgery Middlebury College 1980 - 1984
BS, Biochemistry Nichols School 1975 - 1979

Skills:

Aesthetics, Surgery, Public Speaking, Mentoring, Clinical Research, Teaching, Higher Education, Research, Cancer, Rhinoplasty, Reconstructive Surgery, Plastic Surgery, Public Health, Medicine, Facial Plastic & Reconstructive Surgery, Medical Education, ENT, Healthcare Management, Healthcare, Treatment, Hospitals, Reconstruction, Skin Cancer, Aesthetic Surgery

Interests:

Aesthetic and Reconstructive Surgery of the Face. Dr. Sherris specializes in rhinoplasty, revision rhinoplasty, aging face surgery, and skin cancer reconstruction. At the practice special attention is paid to both the appearance and function of the nose.

Honor & Awards:

Best Doctors of America since 2005 Who's Who in Healthcare Who's Who in Education Who's Who in the World

Dr. David A Sherris - MD (Doctor of Medicine)

Hospitals:

Gromo Institute and Research Center
1237 Delaware Ave, Buffalo 14209
Sisters of Charity Hospital - St. Joseph Campus
2605 Harlem Rd, Cheektowaga 14225
Millard Fillmore Hospital
3 Gates Cir, Buffalo 14209
Gromo Institute and Research Center
1237 Delaware Ave, Buffalo 14209
Sisters of Charity Hospital - St. Joseph Campus
2605 Harlem Rd, Cheektowaga 14225
Millard Fillmore Hospital
3 Gates Cir, Buffalo 14209

Philosophy:

The best interest of the patient is the only interest to consider!

Education:

Medical Schools
University Of Rochester School Of Medicine And Dentistry
Graduated: 1988

Fungal Antigens And Eosinophil Activity

US Patent:

2006016, Jul 27, 2006

Filed:

Feb 28, 2003

Appl. No.:

10/505379

Inventors:

Jens Ponikau - Rochester MN, US
Hirohito Kita - Rochester MN, US
David Sherris - Buffalo NY, US

International Classification:

A61K 39/00, A61K 36/06, C12Q 1/18

US Classification:

424274100, 424195160, 435032000

Abstract:

The invention provides methods and materials related to T cell activation, eosinophil activation, and the ability of eosinophils to attack fungi. The invention also provides animals having a fungal antigen-induced eosinophilic response as well as methods of making such animals and method of using such animals to identify compounds that inhibit an eosinophilic response in an animal.

Detecting A Bacterial Process In Chronic Rhinosinusitis

US Patent:

2010009, Apr 22, 2010

Filed:

Dec 18, 2009

Appl. No.:

12/641868

Inventors:

Jens Ponikau - Amherst NY, US
David Sherris - Buffalo NY, US
Hirohito Kita - Rochester MN, US

International Classification:

G01N 33/573, C12Q 1/44, C12Q 1/28

US Classification:

435 74, 435 19, 435 28

Abstract:

The present invention provides a method for identifying bacterial induced rhinosinusitis. The method comprises obtaining a nasal or paranasal mucus sample and detecting the presence of neutrophil degranulation in the mucus sample. Degranulation of neutrophils can be determined by morphological analysis of the cells in the mucus or by detection of released (i.e., “free”) granule content markers such as neutrophil elastase or myeloperoxidase. Based on an accurate determination of the cause of sinusitis as described herein, an appropriate treatment can be instituted.

Detecting A Bacterial Process In Chronic Rhinosinusitis

US Patent:

7659080, Feb 9, 2010

Filed:

Aug 30, 2007

Appl. No.:

11/897494

Inventors:

Jens Ponikau - Amherst NY, US
David Sherris - Buffalo NY, US
Hirohito Kita - Rochester MN, US

Assignee:

The Research Foundation of State University of New York - Amherst NY
Mayo Foundation For Medical Education and Research - Rochester MN

International Classification:

G01N 33/53, G01N 33/567, G01N 33/00, G01N 33/573, C12N 9/66

US Classification:

435 71, 435 72, 435 721, 435 724, 435 74, 435218

Abstract:

The present invention provides a method for identifying bacterial induced rhinosinusitis. The method comprises obtaining a nasal or paranasal mucus sample and detecting the presence of neutrophil degranulation in the mucus sample. Degranulation of neutrophils can be determined by morphological analysis of the cells in the mucus or by detection of released (i. e. , “free”) granule content markers such as neutrophil elastase or myeloperoxidase. Based on an accurate determination of the cause of sinusitis as described herein, an appropriate treatment can be instituted.

Detecting Fungi In Human Samples

US Patent:

2010010, Apr 29, 2010

Filed:

Aug 12, 2005

Appl. No.:

11/573527

Inventors:

Hirohito Kita - Rochester MN, US
Diane Squillace - Rochester MN, US
David A. Sherris - Buffalo NY, US
Jens Ponikau - Buffalo NY, US
Mark Swanson - Rochester MN, US

Assignee:

MAYO MEDICAL VENTURES - Rochester MN

International Classification:

G01N 33/569

US Classification:

435 731

Abstract:

Methods and materials involved in detecting fungi in human samples are provided herein.